Respiratory Depression
58
3
5
33
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
12 trials with published results (21%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.3%
6 terminated out of 58 trials
84.6%
-2.0% vs benchmark
14%
8 trials in Phase 3/4
36%
12 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 33 completed trials
Clinical Trials (58)
ENA-001 for Opioid Induced Respiratory Depression
Oliceridine Versus Sufentanil Analgesia for Postoperative Patients With Obstructive Sleep Apnea
Vital Sign Monitoring With Continuous Pulse Oximetry and Wireless Clinician Notification After Surgery
Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain
Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia
Transcutaneous Electrical Stimulation for Apnea Detected by Capnography
The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures
Dexmedetomidine vs Propofol in High-Risk ERCP Patients
IPI-Guided Monitoring for Oxygen Desaturation in ERCP
ENA-001 for Post Operative Respiratory Depression (PORD)
Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression
Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age
Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression
Effect of Percutaneous Electrical Acupoint Stimulation on the Improvement of Incidence of Adverse Respiratory Events
Precision Medicine in Anesthesia
Closed-Loop O2 Use During High Flow Oxygen Treatment of Critical Care Adult Patients (CLOUDHFOT)
Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea
Hemidiaphragmatic Paralysis Following Supraclavicular Brachial Plexus Blockade.
VitalThings Guardian Contactless Monitoring